🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier de Saint-Denis
NCT07052604 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023 * Intubated and mechanically ventilated * Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia Exclusion Criteria: * Patients under 18 years old * Patients who refuse the use of their data for research purposes
💊

What it tests

  • Not listed
📍

Where

1 site
Centre Hospitalier de Saint-Denis
Saint-Denis, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy